Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial - PubMed (original) (raw)

Clinical Trial

Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial

Petri Koivunen et al. BMJ. 2004.

Abstract

Objective: To evaluate the efficacy of adenoidectomy compared with long term chemoprophylaxis and placebo in the prevention of recurrent acute otitis media in children aged between 10 months and 2 years.

Design: Randomised, double blind, controlled trial.

Setting: Oulu University Hospital, a tertiary centre in Finland.

Participants: 180 children aged 10 months to 2 years with recurrent acute otitis media.

Intervention: Adenoidectomy, sulfafurazole (sulphisoxazole) 50 mg/kg body weight, given once a day for six months or placebo. Follow up lasted for two years, during which time all symptoms and episodes of acute otitis media were recorded.

Main outcome measures: Intervention failure (two episodes in two months or three in six months or persistent effusion) during follow up, number of episodes of acute otitis media, number of visits to a doctor because of any infection, and antibiotic prescriptions Number of prescriptions, and days with symptoms of respiratory infection.

Results: Compared with placebo, interventions failed during both the first six months and the rest of the follow up period of 24 months similarly in the adenoidectomy and chemoprophylaxis groups (at six months the differences in risk were 10% (95% confidence interval -9% to 29%) and 18% (-2% to 38%), respectively). No significant differences were observed between the groups in the numbers of episodes of acute otitis media, visits to a doctor, antibiotic prescriptions, and days with symptoms of respiratory infection.

Conclusions: Adenoidectomy, as the first surgical treatment of children aged 10 to 24 months with recurrent acute otitis media, is not effective in preventing further episodes. It cannot be recommended as the primary method of prophylaxis.

PubMed Disclaimer

Figures

Fig 1

Fig 1

Trial profile and participant flow

Fig 2

Fig 2

Cumulative occurrence of failures during two year follow up in 180 children, by treatment groups (adenoidectomy, chemoprophylaxis, placebo). Failure recorded if child had two episodes of acute otitis media within two months or three episodes within six months or middle ear effusion that persisted for two months. Protocol violations regarded as drop outs. No significant differences in time to failure between groups (P=0.22 at 6 months; P=0.28 at 24 months, log rank test)

Similar articles

Cited by

References

    1. Sipilä M, Pukander J, Karma P. Incidence of acute otitis media up to the age of 1 1/2 years in urban infants. Acta Otolaryngol 1987;104: 138-45. - PubMed
    1. Teele DW, Klein JO, Rosner B, the Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989;160: 83-94. - PubMed
    1. Alho O-P. How common is recurrent acute otitis media? Acta Otolaryngol (Stockh) 1997;529: 8-10. - PubMed
    1. Lanphear BP, Byrd RS, Auinger P, Hall CB. Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics 1997;99: e1-7. - PubMed
    1. Sade J, Luntz M. Adenoidectomy in otitis media—a review. Ann Otol Rhinol Laryngol 1991;100: 226-31. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources